The shares of Ironwood Pharmaceuticals Inc (IRWD) have recorded the market capitalization of 1.50B
The stock of Ironwood Pharmaceuticals Inc (NASDAQ:IRWD) last traded at $9.63, up 2.45% from the previous session. IRWD stock price is now -0.86% away from the 50-day moving average and -10.17% away from the 200-day moving average. The market capitalization of the company currently stands at $1.50B. With the price target of $15, CapitalOne recently […]
Do investors have a safe investment in Ironwood Pharmaceuticals Inc. (NASDAQ:IRWD)?
In yesterday’s Wall Street session, Ironwood Pharmaceuticals Inc. (NASDAQ:IRWD) shares traded at $8.34, down -2.11% from the previous session. 3 analysts cover Ironwood Pharmaceuticals Inc. (NASDAQ:IRWD), according to research data. The consensus rating among analysts is ‘Overweight’. As we calculate the median target price by taking the range between a high of $20.00 and a […]
Before You Invest In Ironwood Pharmaceuticals Inc. (NASDAQ:IRWD), Consider This Metric
In yesterday’s Wall Street session, Ironwood Pharmaceuticals Inc. (NASDAQ:IRWD) shares traded at $9.61, down -6.79% from the previous session. As of this writing, 3 analysts cover Ironwood Pharmaceuticals Inc. (NASDAQ:IRWD). The consensus rating among analysts is ‘Overweight’. As we calculate the median target price by taking the range between a high of $20.00 and a […]
Is Ironwood Pharmaceuticals Inc. [IRWD] a good investment? Don’t be fooled by its recent momentum
The price of Ironwood Pharmaceuticals Inc. (NASDAQ:IRWD) shares last traded on Wall Street rose 1.84% to $11.05. IRWD stock price is now 3.12% away from the 50-day moving average and -0.09% away from the 200-day moving average. The market capitalization of the company currently stands at $1.69B. With the price target of $15, CapitalOne recently […]
Do investors have a safe investment in Ironwood Pharmaceuticals Inc. (NASDAQ:IRWD)?
In yesterday’s Wall Street session, Ironwood Pharmaceuticals Inc. (NASDAQ:IRWD) shares traded at $10.44, up 0.48% from the previous session. 3 analysts cover Ironwood Pharmaceuticals Inc. (NASDAQ:IRWD), according to research data. The consensus rating among analysts is ‘Overweight’. As we calculate the median target price by taking the range between a high of $19.00 and a […]